Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-02

FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for GALANTAMINE HYDROBROMIDE from Hikma Pharmaceuticals USA Inc., approving the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)

Snippet

SUPPL AP for GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)